arXiv subjects

Ruiji Zhang

Publications and source records attributed to Ruiji Zhang.

3 recordsLinked to original sources

arXiv2024

DRUPI: Dataset Reduction Using Privileged Information

Dataset Condensation (DC) seeks to select or distill samples from large datasets into smaller subsets while preserving performance on target tasks. Existing methods primarily focus on pruning or synthesizing data in the same format as the original dataset, typically being the input data and corresponding labels. However, in DC settings, we find it is possible to synthesize more information beyond the data-label pair as an additional learning target to facilitate model training. In this paper, we introduce Dataset Condensation using Privileged Information (DCPI), which enriches DC by synthesizing privileged information alongside the reduced dataset. This privileged information can take the form of feature labels or attention labels, providing auxiliary supervision to improve model learning. Our findings reveal that effective feature labels must balance between being overly discriminative and excessively diverse, with a moderate level proves optimal for improving the reduced dataset's efficacy. Extensive experiments on ImageNet-1K, CIFAR-10/100 and Tiny ImageNet demonstrate that DCPI integrates seamlessly with existing dataset condensation methods, offering significant performance gains.

cs.CV↗

arXiv2024

PharmaGPT: Domain-Specific Large Language Models for Bio-Pharmaceutical and Chemistry

Large language models (LLMs) have revolutionized Natural Language Processing (NLP) by minimizing the need for complex feature engineering. However, the application of LLMs in specialized domains like biopharmaceuticals and chemistry remains largely unexplored. These fields are characterized by intricate terminologies, specialized knowledge, and a high demand for precision areas where general purpose LLMs often fall short. In this study, we introduce PharmaGPT, a suite of domain specilized LLMs with 13 billion and 70 billion parameters, specifically trained on a comprehensive corpus tailored to the Bio-Pharmaceutical and Chemical domains. Our evaluation shows that PharmaGPT surpasses existing general models on specific-domain benchmarks such as NAPLEX, demonstrating its exceptional capability in domain-specific tasks. Remarkably, this performance is achieved with a model that has only a fraction, sometimes just one-tenth-of the parameters of general-purpose large models. This advancement establishes a new benchmark for LLMs in the bio-pharmaceutical and chemical fields, addressing the existing gap in specialized language modeling. It also suggests a promising path for enhanced research and development, paving the way for more precise and effective NLP applications in these areas.

cs.CL↗

arXiv2024

PatentGPT: A Large Language Model for Intellectual Property

In recent years, large language models(LLMs) have attracted significant attention due to their exceptional performance across a multitude of natural language process tasks, and have been widely applied in various fields. However, the application of large language models in the Intellectual Property (IP) domain is challenging due to the strong need for specialized knowledge, privacy protection, processing of extremely long text in this field. In this technical report, we present for the first time a low-cost, standardized procedure for training IP-oriented LLMs, meeting the unique requirements of the IP domain. Using this standard process, we have trained the PatentGPT series models based on open-source pretrained models. By evaluating them on the open-source IP-oriented benchmark MOZIP, our domain-specific LLMs outperforms GPT-4, indicating the effectiveness of the proposed training procedure and the expertise of the PatentGPT models in the IP domain. Remarkably, our model surpassed GPT-4 on the 2019 China Patent Agent Qualification Examination, scoring 65 and matching human expert levels. Additionally, the PatentGPT model, which utilizes the SMoE architecture, achieves performance comparable to that of GPT-4 in the IP domain and demonstrates a better cost-performance ratio on long-text tasks, potentially serving as an alternative to GPT-4 within the IP domain.

cs.CL↗